Capstone Investment Advisors’s Amicus Therapeutics FOLD Stock Holding History

Capstone Investment Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.84M	Sell	265,730 -1,584,270	-86%	-$22.7M	0.01%	477
2025 Q4	$26.3M	Buy	1,850,000 +1,806,066	+4,111%	+$17.7M	0.05%	148
2025 Q3	$346K	Buy	+43,934	New	+$313K	﹤0.01%	1582
2020 Q4	–	Sell	-37,453	Closed	-$529K	–	1697
2020 Q3	$529K	Buy	37,453 +15,000	+67%	+$219K	﹤0.01%	1159
2020 Q2	$339K	Buy	+22,453	New	+$274K	﹤0.01%	1157
2020 Q1	–	Sell	-4,653	Closed	-$44.2K	–	1232
2019 Q4	$45K	Sell	4,653 -69,147	-94%	-$633K	﹤0.01%	1339
2019 Q3	$592K	Sell	73,800 -10,000	-12%	-$109K	﹤0.01%	1055
2019 Q2	$1.05M	Buy	83,800 +25,900	+45%	+$329K	0.01%	931
2019 Q1	$787K	Buy	+57,900	New	+$707K	0.01%	883
2016 Q4	–	Sell	-26,700	Closed	-$197K	–	995
2016 Q3	$197K	Buy	26,700 +9,968	+60%	+$67.3K	﹤0.01%	689
2016 Q2	$91K	Buy	+16,732	New	+$117K	﹤0.01%	654

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Capstone Investment Advisors's FOLD Position: Q1 2026 in Review

Capstone Investment Advisors reduced its Amicus Therapeutics (FOLD) stake by 86% in Q1 2026, selling an estimated $22.7M and leaving 265,730 shares worth $3.84M. The position accounts for 0.01% of the portfolio, ranked #477.

Capstone Investment Advisors first reported a position in FOLD in Q2 2016 and has held it in 11 quarters since. The position peaked at $26.3M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Capstone Investment Advisors held 265,730 shares of Amicus Therapeutics worth $3.84M as of Q1 2026.
Capstone Investment Advisors sold 1,584,270 Amicus Therapeutics shares in Q1 2026, an estimated $22.7M.
Amicus Therapeutics made up 0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #477 holding.
Capstone Investment Advisors first reported a position in Amicus Therapeutics in Q2 2016 and has held it in 11 quarters since.
Capstone Investment Advisors's Amicus Therapeutics position peaked at $26.3M in Q4 2025.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.